TP53 and acute myeloid leukemia: In previously reported next-generation sequencing of primary AML samples, recurrent mutations in >20 different genes were demonstrated.27 In this subset of genes, we observed mutations in TP53 (P72R), TET2 (V218M and I1762V) and FLT3 (T227M) in all four cell lines (Figure 2b).